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Abstract
Background
Patient support during tuberculosis treatment is expected to be more often available and
more customized in low tuberculosis incidence, high-resource settings than in lower-
resource settings. The aim of this systematic review is to provide an overview of tuberculosis
patient support interventions implemented in low-incidence countries and an evaluation of
their effects on treatment-related outcomes as well as their acceptability by patients and
providers.
Methods
PubMed, Social Science Citation Index and Cumulative Index to Nursing and Allied Health
and Literature were searched for the period 01.2006–05.2016 on publications describing
tuberculosis patient support interventions in low-incidence countries (<20 patients per
100,000 population).
Results
Through our search strategy, 1875 unique publications were identified. Forty publications
were included: 17 evaluated patient support quantitatively, 9 qualitatively and 14 only
described the patient support. Nineteen publications assessed treatment supervision
options only, 21 assessed (combinations of) treatment supervision, socio-economic, psy-
cho-emotional, health-educational and other support. Of eight studies quantitatively evaluat-
ing the effects of support with a control group, four showed positive effects: two out of three
that used combinations of patient support and two out of five that compared treatment
supervision options. Heterogeneity of interventions precluded pooling of results. Qualitative
and descriptive studies showed that patients appreciated individualized support including
treatment supervision, psycho-emotional and socio-economic support; and digital health
interventions.
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Conclusion
Our review shows that a variety of patient support interventions is implemented in low-inci-
dence countries. Although only a few interventions were evaluated quantitatively, we identi-
fied potential best practices. The scarcity of evidence on effectiveness, however, indicates
the need for further research to evaluate potential best practices.
Introduction
Ensuring adherence to anti-tuberculosis (TB) treatment is a challenge, not only in high TB
burden countries but also in countries with a low TB incidence and well-financed health care
systems. Addressing barriers to TB diagnosis and treatment adherence for vulnerable and
hard-to-reach groups are priority action areas for low-incidence countries progressing towards
TB elimination. Detection of TB is high in most low-incidence countries through good access
to care and enhanced case finding among risk groups [1]. Adherence to TB treatment, how-
ever, remains a challenge given the long treatment duration with multiple antibiotics; at least
six months for drug-susceptible TB and 18–24 months for multidrug-resistant TB (MDR-TB),
i.e. TB resistant to at least the two key first-line anti-TB drugs isoniazid and rifampicin [2,3].
Adverse drug reactions, early improvement of symptoms during treatment and socio-eco-
nomic difficulties of the patient contribute to non-adherence to treatment, even in countries
with relatively well-financed health care systems [4–11]. Interventions to ensure TB treatment
adherence are not only essential in increasing the chance of cure but also in reducing the risk
of further TB transmission and of drug resistance development [12–15].
There are various forms of patient support interventions to alleviate or remove barriers to
treatment adherence including use of treatment supervision, also known as directly observed
therapy (DOT), and other treatment administration support forms such as provision of pill
boxes; health education; socio-economic support; and psycho-emotional support. Patient sup-
port interventions have been systematically reviewed and evaluated, but not yet specifically
focussing on low-incidence countries [16–21]. Most of the studies reviewed, focused on high
TB burden countries with limited financial resources or only on special risk groups. Patient
support in low-incidence countries, however, may differ from support in high-incidence coun-
tries as in the former setting there usually are less patients and more resources. Patient support
in high-resource countries may be more tailored to the individual patient’s needs and make
more use of digital innovations, such as video observed treatment (VOT) [1,7]. In VOT medi-
cation intake is monitored through videos recorded by the patients or through video calls. In
high-incidence countries interventions need to be provided to a larger number of patients rep-
resenting a broader spectrum of the society, while resources are more limited.
In the Netherlands, all TB patients are entitled to support by a specialized TB nurse. This
support may comprise health education, counselling, incentives and enablers. TB nurses also
act as a case manager for the patient and coordinate the organization of treatment supervision,
further socio-economic and psycho-emotional support. DOT can be provided by the TB nurse
and/or a selected third party such as home nursing services. TB nurses determine the nature
and intensity of support individually per patient based on an assessment at the start of treat-
ment. For this assessment, the TB nurses interview patients in a structured way on disease-
related factors, such as symptoms and co-morbidities, as well as on socio-economic and psy-
cho-social factors. In the Netherlands, these factors are regarded essential for successful treat-
ment. The patient should be well-informed (empowered), motivated to complete TB
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treatment, should be in financial and social stable living conditions, and side-effects and co-
morbidities should be managed [22,23].
Treatment results in the Netherlands are satisfactory with 88% successful treatment out-
come for rifampicin-sensitive TB for the years 2009–2013 [24]. As current patients support
practices are not evidence-based, however, the question has been raised as to what are the
most effective and efficient means of providing TB patient support. To develop an evidence-
based Dutch guideline on patient support which may also be informative for other low-inci-
dence countries, KNCV Tuberculosis Foundation initiated the project ‘Improving Patient Sup-
port Interventions’. This project includes a systematic review on evidence for patient support
interventions in low-incidence countries, a European survey on countries’ patient support pol-
icies, and a qualitative study capturing the current Dutch practices.
Objective
The aim of this review is to provide an overview of published TB patient support interventions
in low-incidence countries, including their effectiveness in improving treatment adherence as
well as their acceptability by patients and providers.
Methods
Eligibility criteria
As the aim of our systematic review was to identify evidence on patient support most relevant
to low TB incidence settings such as the Netherlands, we only included publications describing
TB patient support interventions in low-incidence countries [25]. Low incidence was defined
as less than 20 per 100,000 population in line with the definitions of the European Centres of
Disease Control [26]. Publications from all countries that had reached low TB incidence by
2014 were included [27]. Patient support interventions were defined as any intervention aim-
ing to increase treatment adherence. Studies were excluded if they only compared adherence
under different regimen options such as daily vs. thrice weekly doses. All publications measur-
ing any qualitative or quantitative outcomes of patient support were included. Additionally,
we included publications describing patient support as an ancillary intervention to the primary
intervention under study, and the patient support component not being evaluated. Only arti-
cles published since 2006 were included as we aimed to capture the impact of recent evidence
and practices, e.g. utilizing online interventions. We included publications in Dutch, English,
German, Portuguese, Spanish, Italian and Russian.
Search strategy. The bibliographic database PubMed was searched on April 15th, 2016
and the databases Cumulative Index to Nursing and Allied Health and Literature (CINAHL)
and Social Science Citation Index (SSCI) were searched on May 2nd, 2016 to identify relevant
publications on patient support interventions. Search terms were developed by the authors
and included combinations of three domains: (i) “tuberculosis” and related terms, (ii) “patient
support interventions” and related terms and (iii) “treatment adherence” and related terms. A
complete list of search terms is provided in S1 Appendix. Reference lists of relevant systematic
reviews and of the included publications were scanned to identify additional publications.
Publications eligible for inclusion were selected in three steps: (i) screening of titles, (ii)
assessment of abstracts and (iii) assessment of full texts. Titles and abstracts were assessed on
eligibility independently by two researchers (SB and SH). Full text selection and review of ref-
erence lists was performed by one researcher (SB) and verified by a second reviewer (SH). Dis-
crepancies between reviewers were resolved by discussion.
Data collection and analysis. Characteristics of patient support interventions were
entered into a pre-piloted form. Extracted characteristics included the country where the
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intervention was provided, a description of the study design including, on availability, a
description of the intervention and the control group. We divided patient support interven-
tions into five categories: Treatment supervision, treatment administration support other than
DOT, health educational (HE) support, socio-economic (SE) support and psycho-emotional
(PE) support. These categories were defined as follows:
• Treatment supervision: Direct observation of medication intake by any person, at any loca-
tion in any frequency, also known as directly observed therapy (DOT)
• Treatment administration support other than DOT: Tracer, pill boxes and other measures
other than DOT to promote adherence
• HE support: Presentation of information to the patients aiming to educate them about their
disease and its’ treatment as well as related health issues
• SE support: Provision of (social) services, material goods and/ or financial support
• PE support: Interventions focusing on the patients’ feelings, emotions or social relationships
and social support
The following information was compiled on the interventions described in the publications:
intervention categories included, reasons for patient support, patients eligible for the support,
support provider(s), level of implementation (e.g. national/regional), duration of patient sup-
port provision, and experiences with provision. If available, also quantitative treatment adher-
ence-related outcomes of the intervention were extracted. Treatment adherence-related
outcomes as defined and calculated in the respective studies were adopted without changes.
Risk of bias in individual studies and quality of evidence. Risk of bias for studies quanti-
tatively evaluating effects of patient support interventions against a comparison group was
assessed using The Cochrane Collaboration’s Tool for Randomized Controlled Trials (RCT)
for RCT and Newcastle Ottawa Scale (NOS) for Non-Randomized Studies (NRS). For NRS
<10% of subjects lost was considered as indicative of low risk of attrition bias.
Summary measures and synthesis of results. Patient support interventions were
described per category. Quantitative outcomes among patients receiving the interventions
were described and, if applicable, compared to those among a comparison group of patients.
Dichotomous outcomes were described using risk ratios (RR) for cohort studies and con-
trolled trials and odds ratios (OR) for case-control studies, both with corresponding 95% con-
fidence intervals. If not provided in the publication, ratios were calculated from the data
provided in the publications, if possible. For non-dichotomous outcomes, absolute and relative
differences (dr) were calculated. Ratios and relative differences were calculated using Microsoft
Excel (2013).
Results
Publication selection
Through our search strategy, 2434 publications were identified of which 559 were duplicates
and removed. From the remaining 1875 publications, 40 were eligible for inclusion (S1 Fig).
Study characteristics
The 40 publications included 27 observational studies (cohort studies [28,29,38–41,30–37],
case series [42–47], case-control studies [48–51], cross-sectional studies [9,52], and a costing
study [53]); 9 descriptive qualitative studies (interview studies [54–59], a community-based
Patient support for tuberculosis patients in low-incidence countries: A systematic review
PLOS ONE | https://doi.org/10.1371/journal.pone.0205433 October 10, 2018 4 / 24
ethnography [60], a focused ethnography [61], and an interpretive phenomenology [62]); 3
experimental studies (RCTs [63,64]), and a non-randomized controlled trial [65]) and 1 quasi-
experimental study (historical before-after comparison) [66].
Publications were from the USA [29,31,53,64,65,35,36,41,42,44,46,47,50], the UK [9,43,51,
54,57,61], Spain [30,32,38,40], Japan [52,56,59], Turkey [37,48,63], Canada [34,62], Australia
[39], Greece [49], Italy [45], the Netherlands [28], New Zealand [60], Norway [58], Saudi Ara-
bia [66] and Switzerland [33]. One study was multi-national, participating countries being
Armenia, Australia, Central African Republic, India, Philippines, South Africa, Swaziland,
Uganda and the UK [55]. Twenty-six studies evaluated patient support intervention qualita-
tively and/or quantitatively [30,35,49–51,54–60,38,61–66,39–41,43–45,48] (Table 1).
Treatment support described
Of the 40 publications on TB patient support, 36 included treatment supervision options
[9,28,39–48,30,49,50,52–54,56–60,31,62,64–67,32,33,35–38] (19 as the sole patient support
intervention [9,29,39,41,42,45,48,50,58,64,30–33,35–38]), 12 included SE support [34,43,61,
62,46,47,52,53,56,57,59,60] (1 as the sole intervention [61]), 11 included PE support [34,40,62,
51,53–57,59,60] (1 as the sole intervention [55]), 8 included HE support [47,49,51,57,59,62,
63,66] and 6 included treatment administration support other than DOT [44,54,59,63,65,66].
Nineteen publications described support packages of more than one patient support category
[34,40,54,56,57,59,60,62,63,65,66,43,44,46,47,49,51–53]. An overview of the support described
per category is provided in S2 Appendix.
Levels of intervention implementation, providers and target populations of patients support
were specified in 33 [28,29,40,41,43–49,51,30,52–56,58,60–63,33,64–66,34–39], 20 [28,33,56–64,
66,39–41,49,51–54] and 26 [28,30,46,47,49,51,52,54–58,34,59–61,63,64,66,35,38,40,41,43–45] pub-
lications, respectively (Table 1). Interventions were organized mostly on a local [29,34,62,63,35,
36,38,43,47,48,51,61] or regional level [33,37,39,41,46,49,53,60,66]. Providers were mostly (n = 13)
TB-, public health- or general nurses [28,39,61,62,66,40,52,53,56–60]. Most interventions (n = 20)
were specifically aimed at patients at increased risk of non-adherence [28,30,52,54–57,59–61,64,
66,34,38,40,41,43,45,46,51] such as substance abusing patients [30,38,66,45,46,51,52,54,57,59,64],
homeless [30,34,51,52,56,57,59], MDR-TB patients [28,38,41,55], immigrants [38,45,61], and pris-
oners [30,51]. Six publications from Greece, Norway, the US and Turkey described interventions
that were provided to all TB patients [35,44,47,49,58,63]. These interventions were mostly (n = 5)
forms of DOT [35,44,47,49,58].
Treatment supervision options. DOT was described in 36 publications [9,28,37–46,29,
47–50,52–54,56–58,30,59,60,62,64–66,31–36], and mostly (n = 27) comprised of out-patient
DOT [29,33,46–50,52–54,56,57,34,58–60,62,64–66,35,36,38,39,41,43,44] provided at various
locations, for example at the patient’s home [47,49,58,60], the pharmacy [33,43,52,54,57], the
drug dependency unit [38,43,54], homeless shelters [46,54], on the streets or in public bars
[46,57,62]. Out-patient DOT at the health centre was described in four publications [38,48,
52,56]. Providers of DOT were mostly health care workers (n = 19) [1,9,53,54,56–60,62,
66,28,33,34,39,40,48,49,52]. In one study, DOT was provided by social workers [41] and in
another one by peers, who were former substance users [64].
VOT was described in four publications [36,39,44,65].
HE support and treatment administration support other than DOT. Treatment admin-
istration support other than DOT, mentioned in six publications, [44,54,59,63,65,66], was
combined with HE support in four instances, and mostly (n = 5) included reminders by the
treatment supporter and/or outreach workers [51,54,63,65,66]. One study described the provi-
sion of a pill case [59]. HE support, mentioned in eight publications [47,49,51,57,59,62,63,66],
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comprised in seven publications of health care workers involved in treatment supervision,
mostly TB/ public health nurses, explaining about TB and its treatment [47,49,57,59,62,63,66].
One publication described awareness rising supported by peers [51].
SE- and PE Support. SE- and PE support were mentioned in 12
[34,43,61,62,46,47,52,53,56,57,59,60] and 11 [34,40,62,51,53–57,59,60] publications, respec-
tively, of which 7 overlap [34,53,56,57,59,60,62]. The types of SE support described were mate-
rial or directly provided enablers (n = 8) [34,46,47,56,57,59,60,62], help in accessing social or
welfare services (n = 8) [43,47,53,56,57,59–61] and the provision of incentives (n = 6)
[34,46,52,53,57,59] such as job trainings [59] and financial support [34,46,53]. In most publica-
tions (n = 9) SE support was part of the routine care health care workers provided to TB
patients [34,47,53,56,57,59–62]. In one study, a dedicated “TB link worker” was responsible
for helping patients in accessing social care [43]. PE support mostly (n = 5) comprised of TB/
public health nurse supervising treatment building rapport providing moral support for the
patient [56,57,59,60,62]. Other PE support interventions included accompanying patients to
(clinic) appointments [43,51,60], counselling by a clinician and a psychologist [40], a DOT
completion ceremony [56] and blogging about treatment [55].
Quantitative evidence on patient support described
Patient support is quantitatively evaluated in 17 studies; in 8 with comparison to a control
group and in 9 without comparison to a control group.
Studies quantitatively evaluating patient support compared to a control group. Of the
eight studies that compared a patient support intervention with a control group
[30,35,39,48,63–66], five evaluated different forms of treatment supervision options
[35,39,48,63–66], one evaluated treatment supervision combined with reminders[65]; and two
evaluated provision of HE support combined with reminders [63,66]. In four studies, interven-
tions were associated with a significant improvement in treatment adherence. Patients whose
treatment was supervised by peers had a lower risk of treatment failure compared to patients
whose treatment was supervised by health workers (RR = 1.40 [CI: 1.08–1.82]) [64]. Patients
whose treatment was supervised at a location convenient to them were more likely to success-
fully complete treatment compared to patients on self-administered treatment (SAT)
(RR = 1.14 [CI: 1.07–1.22]) [35]. Patients who received HE support combined with reminders
were more likely to attend 100% of the follow-up visits and to complete treatment, respectively,
compared to patients receiving routine care (RR = 1.83 [CI: 1.1–2.9]; RR = 1.16 [CI: 1.11–
1.20]) [63,66]. In the other four studies [30,39,48,65], patient support interventions had no sta-
tistically significant effect on treatment adherence. In one of these studies, treatment outcomes
were not influenced by the type of DOT provider, i.e. health workers versus other providers
[48]. In two of these studies, VOT was not superior compared to in-person DOT in terms of
treatment completion (RR = 1.49 [CI: 0.95–2.33]; RR = 0.99 [CI: 0.93–1.05]) [39,65]. VOT,
however, did increase effectivity in terms of the number of successful observations (RR = 1.05
[CI: 1.04–1.06]; dr (average number of non-observations) = -67%). DOT was also not superior
compared to SAT in terms of less adverse treatment outcomes and less treatment default,
respectively (RR = 1.12 [CI: 0.59–2.11]; OR = 1.37 [CI: 0.85–2.21]) [30,48]. An overview of the
outcomes of the interventions is provided in Table 2.
Studies quantitatively evaluating patient support without comparison to a control
group. Of the nine studies that quantitatively evaluated patient support without comparison
to a control group [40,41,43–45,49–51,68], seven evaluated different forms of DOT
[40,41,44,45,49,50,68], one evaluated SE support [43] and one combined HE support with PE
support and reminders [51] (Table 3). Under the different forms of DOT, treatment
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Table 2. Quantitative outcomes and effects of tuberculosis patient support interventions in low-incidence countries described in studies allowing for comparison to
a control group.
Source Target group Intervention (comparison) Outcome1 N IG CG Effect (95%
CI, p value)
Babalık et al., 2013
[48],
Turkey
Adult TB patients with one
year follow-up
DOT (SAT) Adverse treatment outcome
(default, death, and treatment
failure)
905
(IG:830,
CG:75)
431
(52%)
33
(44%)
OR2 = 1.37
[CI:0.85–2.21]
DOT at the health care centre
(DOT at the dispensary)
581 (IG:415,
CG:166)
206
(50%)
93
(56%)
OR3 = 0.92
[CI:0.63–1.36]
DOT at other locations (DOT
at the dispensary)
415 (IG:249,
CG:166)
132
(53%)
93
(56%)
OR3 = 0.88
[CI:0.57–1.36]
SAT (DOT at the dispensary) 241 (IG:75,
CG:166)
33
(44%)
93
(56%)
OR3 = 0.69
[CI:0.38–1.26]
SAT (DOT by HCW) 702 (IG:75,
CG:627)
33
(44%)
322
(51%)
OR3 = 0.73
[CI:0.43–1.23]
DOT by others (DOT by
HCW)
830 (IG:203,
CG:627)
109
(54%)
322
(51%)
OR3 = 0.88
[CI:0.61–1.26]
Caylà et al., 2009
[30], Spain
TB Patients at high risk of low
adherence
DOT (SAT) Treatment default 1424
(IG:140,
CG:1284)
10
(7%)
82
(6%) OR4 = 1.12
[CI:0.57–2.22]
Chaudhry et al.,
2015 [66], Saudi
Arabia
Infectious PTB patients Revised patient retrieval
system (vs. baseline phase)
Treatment completion 1336
(IG:835,
CG:501)
816
(98%)
423
(84%)
RR = 1.16
[CI:1.11–
1.20], p<0.01
Retrieval after missed
appointments
239
(IG: 98,
CG:141)
79
(81%)
63
(45%)
RR = 1.80
[CI:1.47–
2.22], p<0.01
Chuck et al., 2016
[65], USA
Patients eligible for DOT Synchronous VOT (vs. in-
person clinic and community
DOT)
Treatment completion 316
(IG:49,
CG:267
47
(96%)
260
(97%)
RR = 0.99
[CI:0.93–1.05]
Number of successful DOT
sessions
3292
(95%)
32204
(91%)
RR = 1.05
[CI:1.04–
1.06], p<0.01
Clark et al., 2007
[63], Turkey
First-time patients, newly
diagnosed, receiving first-line
drugs
Pharmacist-led patient
education (vs. routine medical
and nursing care)
Number of patients who
attended 100% of the follow-up
visits
114
(IG:56,
CG:58)
30
(54%)
17
(29%)
RR = 1.83
[CI:1.1–2.9],
p = 0.01
Number of patients with 100%
of isoniazid metabolites test
results positive
103
(IG:51,
CG:52)
41
(80%)
22
(42%)
RR = 1.90
[CI: 1.4–2.7],
p<0.01
Observed / expected doses taken 88.7% 85.8% dr = 3%,
da = 2.9%
[CI:-0.83–
6.63]
p = 0.13#
King, Munsiff and
Ahuja, 2010 [35],
USA
Patients treated with
Rifabutin, on DOT
voluntarily or due to non-
adherence
Ever on DOT (never DOT) Treatment success 2411
(IG:1819,
CG:592)
1494
(82%)
325
(55%)
OR5 = 2.82
[CI:1.88–4.25]
Ricks et al., 2015
[64], USA
Substance abusing patients DOT by Department of Public
Health personnel (vs
enhanced DOT)
Treatment failure 94
(IG:48,
CC:46)
8
(15%)
18
(39%)
RR6 = 2.7
[CI:1.2–5.8]
p = 0.01
Mean number of treatment
interruptions
1.4 4.5 dr = -69%
p = 0.06¥
Mean treatment length of
interruptions (measured by
number of interruptions)
1.3 2.7 dr = -52%
p = 0. 42¥
(Continued)
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Table 2. (Continued)
Source Target group Intervention (comparison) Outcome1 N IG CG Effect (95%
CI, p value)
Wade et al., 2012
[39], Australia
Patients eligible for DOT VOT (vs. in person home and
clinic DOT)
Treatment completion 115
(I:45, C:70)
22
(49%)
23
(33%)
RR = 1.49
[CI:0.95–
2.33], p = 0.08
Average number of non-
observations
13.4 40.6 dr = -67%,
da = 27.5
[CI:16.6–40.0]
Proportion of episodes not
observed
12.1% 31.1% dr = 61%,
da = 18.9%
[CI:12.2–25.4]
descriptions of the target groups can be found in S2 Appendix
#statistical analysis consisted of Student’s T-test
¥statistical analysis consisted of Wilcoxon rank-sum test
CG: control group, CI: Confidence Interval, da: absolute difference, DOT: Directly Observed Treatment, dr: relative difference, IG: intervention group, N: number, OR:
Odds Ratio, PTB: Pulmonary TB, RR: Risk Ratio, TB: Tuberculosis, VOT: Video observed treatment
1 Outcome as reported in the respective publication, may comprise desirable and undesirable outcomes
2 OR calculated based on data provided in the publication
3 Adjusted OR provided in the publication
4 OR provided in the publication
5 Adjusted OR provided in the publication
6 Adjusted RR provided in the publication
https://doi.org/10.1371/journal.pone.0205433.t002
Table 3. Quantitative outcomes of tuberculosis patient support interventions in low incidence countries described in studies not allowing for comparisons to a con-
trol group.
Source Intervention Target group N Outcome N
outcome
Charokopos et al., 2013
[49], Greece
Modified DOT Newly diagnosed TB patients 54 Treatment completion 11 (85%)
Craig et al., 2008 [43],
UK
TB link worker Adult TB/LTBI patients referred on the
basis of social need to TBLW
90 Treatment completion 70 (78%)
Escudero et al., 2006
[40], Spain
In-patient DOT HIV-negative MDR-TB patients 25 Treatment completion 21 (84%)
Ferrer et al., 2010 [41],
USA
DOT by social worker MDR-TB patients 46 Treatment completion 30 (65%)
Garfein et al., 2015 [44],
USA
VOT via uploading videos via a smart phone
app + daily text message reminders
Adult newly diagnosed DS TB patients
treated under VOT
41 Treatment adherence [average
doses missed]
2.7±7
Treatment adherence [observed
doses/ expected doses]
93%
Jit et al., 2011 [51], UK Find and Treat Service Hard to reach individuals with active
PTB
188 Treatment completion# 61%
Luzzati et al., 2011 [45],
Italy
In-patient DOT Adult patients admitted to referral TB
Centre for high risk
122 Treatment adherence [not
defined]
96%
Mejuto et al., 2010 [38],
Spain
DOT at various locations TB patients who received DOTS
treatment
253 Treatment completion 213 (82%)
Pursnani et al., 2014
[50], USA
Out-patient DOT Patients on out-patient DOT 70 Treatment completion 62 (89%)
descriptions of the target groups can be found in S2 Appendix
#Based on modelling data
DOT: Directly Observed Treatment, N: number, PTB: Pulmonary TB, TB: Tuberculosis, VOT: Video observed treatment
https://doi.org/10.1371/journal.pone.0205433.t003
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Table 4. Qualitative outcomes of and experiences with tuberculosis patient support interventions described in low incidence countries.
Study Intervention Outcomes
Bender et al., 2011 [62],
Canada
TB nurses provide DOT at patients’ homes, nurses’ cars, the street
and other public settings; Nurses repeatedly explain and clarify
treatment plan; Nurses provide incentives; Nurses build rapport,
encourage adherence without being authoritarian
Patients emphasized the emotional well-being that came from the
way that nurses addressed fears, challenged the stigma of TB, and
helped with other health concerns; In some cases, nurses felt like
intruders; The dual surveillance-care focus of client visits required
nurses to balance the intrusiveness of these visits with a welcoming
and friendly approach providing comfort to the patient
Chuck et al., 2016 [65],
USA
Synchronous VOT Fifty-nine patients reported choosing VOT due to its convenience,
four for privacy and one for flexibility; 346 VOT-related issues were
identified for 54 patients (276 technical problems, 49 patient-related
challenges such as patients forgetting their appointment, having
schedule conflicts, or patient being out of camera view, 21 due to
smartphone misuse)
Craig and Zumla, 2015
[54], UK
DOT is provided at the drug dependency unit, the pharmacy in
conjunction with methadone and at hostels via outreach workers,
Outreach workers accompany patients to appointments and provide
appointment reminders
Patients felt resentment when DOT was provided in an
authoritarian atmosphere; DOT was not always successful even
when the location or provider was changed; Substance abusers did
not always attend the drug dependency unit where DOT was
provided due to travel distance or drug use; Quality of monitoring
of pill swallowing varied across different healthcare locations;
Outreach workers were not always reliable in providing reminders
Craig et al., 2008 [6], UK TB link worker helps patients with challenging health and social
care needs to access community services
The introduction of the TB link worker improved communication
of out-patient and in-patient care providers, particularly in relation
to hospital discharge, lead to additional time for care providers,
increased information exchange and awareness of the disease among
care provider, ensured patients received intensive emotional and
practical support in a ‘one-stop-shop’ fashion which was an
incentive for patients to engage with the services; Goals jointly
agreed on by patient and TB link worker (concerning housing,
immigration, income/benefits, treatment completion, DOT, drug-
and alcohol support, criminal justice) were totally achieved for 57%
(38/67) of patients and partially achieved for 31% (21/67), 3 patients
refused assistance from the TB link worker; for 12 cases goals were
not achieved because: patients did not contact the community
services (n = 5), patients were not considered eligible to receive the
service (n = 4), patients refused the housing offered to them (n = 2),
there were no vacancies at the hostel (n = 1)
Garfein et al., 2015 [44],
USA
Asynchronous VOT Thirty-eight patients (92.7%) would choose VOT if repeat of anti-
TB treatment was needed; All would recommend VOT to other TB
patients; 24 (60%) found text message reminders helpful; Nurses
reported that time and travel saved using VOT allowed them to
concentrate on less adherent patients; VOT providers contacted
patients to encourage adherence, provide re-training on VDOT
procedures, and/or troubleshoot technical problems with recording
videos. Older participants perceived experienced no barrier to using
VDOT but enjoyed learning to use a smartphone and the autonomy
related to VOT,
Gerrish, Naisby and
Ismail, 2013 [61], UK
Somali health care workers and TB nurses help patients to access
other health and welfare services
The support of TB specialist nurses and Somali health workers was
highly valued by patients and healthcare professionals
Horter et al., 2014 [55],
Multinational
Blogging about MDR-TB treatment Patients mentioned blogging about MDR-TB treatment was
supportive for adherence, considered blogging a tool to receive and
provide peer support, a platform to express themselves and mean to
record their achievement of which they can be proud; Stakeholders
considered blogging a tool to provide treatment support to patients
and to empower patients; Project staff and stakeholders considered
blogging a tool to enhance patient practitioner relationships and to
improve the understanding of the patient’s experience with the
disease; One blogger mentioned expectations of financial gain as a
result of blogging
(Continued)
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completion/ cure rates ranged from 70% to 89%. Treatment completion was 78% in one study
in which SE support was provided to patients [43] and 61% in one study in which HE support
combined with PE support and reminders was provided to patients [51].
Acceptability of patient support described
Thirteen studies qualitatively described how acceptable patient support was to patients and
providers (Table 4). Patients appreciated individualized support by nurses [56,60,62] which
included DOT at the patients home [60,62] or the health care centre [56] but also various
forms of psycho-emotional support, such as nurses providing food and building rapport.
Interventions appreciated by patients as well as providers included VOT [39,44,65], a “TB link
worker” [43], blogging about TB [55], and Somali health care workers providing support,
together with specialized TB nurses, for people of Somali origin living in the UK [61]. Patients
appreciated VOT due to its convenience, privacy and flexibility [39,65]. Providers were satis-
fied with VOT due to travel time saved [44] and the ability to easily assess patients repeatedly
[39]. Some obstacles were encountered by providers, which were mainly of a technical nature
Table 4. (Continued)
Study Intervention Outcomes
Kawatsu et al., 2013 [56],
Japan
Nurses provide DOT at the public health centre, and food and
drinks when patients come for DOT; Nurses consult social welfare
offices and other organizations; Nurses build rapport, address
concerns and organize congratulation ceremony for successfully
completed treatment
Patient empowerment was achieved comprising the fulfilment of
emotional needs, improved mental health, improved health
behaviour, improvement of living environment, improved
interpersonal relationships and improved attitudes towards society
Mtui and Spence, 2014
[57], UK
DOT is provided by the general practitioner; TB nurses provide
DOT in pharmacies for substance-abusers, on the streets / public
bars by TB nurses for homeless patients; Nurses talk about TB and
provide leaflets; Nurses assist in accessing social care while
delivering DOT, provide incentives for some cases and bring people
to the clinic; Nurses build rapport with patients, support in coping
with the treatment and perform home visits
Nurses reported that lengthy time for travel, long duration of visits,
and high number in receipt of DOT were challenging; One National
Health Service board reported threats to nurses from people known
to patients while visiting; One National Health Service board
reported problematic treatment adherence with the immigrant
population due to fears of deportation
Sagbakken, Bjune and
Frich, 2011 [58], Norway
DOT by homebased
nursing services
Some patients had the experience of being cared for by DOT
provision; Most patients experienced DOT as humiliating and
discriminating as there was little room for patients to negotiate
whether they consent to DOT, because DOT appointments could
not be scheduled flexibly and because the health care worker
proving DOT changed frequently
Searle, Park and Littleton,
2007 [60], New Zealand
DOT is provided at home by public health nurses; Nurses ease
structural constrains by arranging housing, food and transport;
Nurses provide moral support and encouragements
One patient appreciated the encouragement of the public health
nurse and the monthly visits; One patient appreciated the nurse’s
sensitivity regarding stigma; One patient appreciated the nurse’s
flexibility in planning meetings around his business trips
Shimamura et al., 2010
[59], Japan
Pill case provided by public health nurse For one patient with dementia who hoped to take her medicine
independently a pill case created by the public health nurse
facilitated adherence
Wade et al., 2012 [18],
Australia
Synchronous VOT Patients valued the convenience, flexibility and reliability and
privacy of VOT, developed rapport with the nurses via VOT and
found the technology was easy to use; Nurses reported that many
more patients could be seen in a shift than with a drive-around
service, more convenient scheduling was regarded as improving
patient adherence, absent patients could be readily called back
repeatedly and patients who had difficulty taking all their tablets at
once could be called in stages; Frustrating, substantial and ongoing
problems with video call quality were reported as well as the
potential to not swallow the pills correctly
DOT: Directly Observed Treatment, MDR: multi-drug resistant; TB: Tuberculosis, VOT: Video observed treatment
https://doi.org/10.1371/journal.pone.0205433.t004
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and patient-related challenges such as patients not following observation protocols [39,65].
The “TB link-worker” was generally appreciated by patients as they had to go only to one
“stop” for both social and emotional support. After the introduction of the TB link worker,
88% of the patients achieved jointly set goals such as temporary housing and secured income.
Stakeholders appreciated additional time and increased information and knowledge exchange
with the clinical teams [43]. Blogging was perceived, both by patients and providers, as a tool
to empower patients [55].
For both patients and providers challenges were reported related to DOT provision.
Lengthy travel time was mentioned as an obstacle for patients when DOT was provided in the
health facility [54] and for providers when DOT was provided at the patient’s home or the
community [39,44,57,65]. Also long duration of the home-DOT visits themselves and threats
from the vicinity while visiting patients were reported to be obstacles for HCW [57]. Home-
based DOT by a general nursing service implemented in Norway was perceived as humiliating
and discriminating by some patients. They felt that there was little room to negotiate whether
they consent to DOT. Some patients perceived inflexible DOT appointments as frustrating as
it restricted their daily activities. Frequent changes in health care workers proving DOT ham-
pered the establishment of a trustful relationship between the patients and providers [58].
Risk of bias within studies. Risk of bias was assessed for RCT (n = 2) [63,64] as well as for
NRS with a control arm (n = 6) [30,35,39,48,65,66]. For both RCT there was an unclear risk of
bias, i.e. insufficient information provided to determine the risk of bias, in more than one key
domain (S3 Appendix). For all NRS a risk of bias was identified in one or more domains (S4
Appendix, S5 Appendix).
Discussion
Our systematic review included 40 publications describing a variety of support interventions
for TB patients in low-incidence countries; interventions that we categorized into DOT, SE
support, PE support, HE support and other support. Only eight studies compared the inter-
vention with a control group: six treatment supervision options (with reminders) and two HE
support with reminders. In four of these studies the intervention(s) significantly increased
treatment adherence and completion. Providing health education and reminders for medica-
tion intake and appointments [63,66], DOT by peers [64] and DOT at any location convenient
to the patient [35] improved treatment adherence. DOT at the health care centre or the dispen-
sary [48] and VOT [39,65] did not improve adherence. Qualitative and descriptive evaluations
of patients’ experiences with treatment support showed that patients appreciate individualized
support by nurses [56,60,62] or a “TB link worker” [43] including DOT, psycho-emotional as
well as socio-economic support, and digital health interventions such as VOT as opposed to
traditional forms of DOT [39,44,65] and blogging about TB [55]. These interventions may be
beneficial in TB patient support in low-incidence countries.
Based on the evidence found in this review, combining health education and appointment/
medication reminders might be considered a best practice in TB patient support. The com-
bined effect of health education and reminders has not been systematically reviewed yet. The
importance of patient education in TB case management, however, was highlighted in another
recent systematic review [69]; the success rate of treatment as well as the confirmed cure rate
was significantly higher in the group receiving an intensive triad model (health education
combined with support) compared to the control group. A review on reminder systems
showed that appointment-reminders had a significant effect on treatment success and can be a
valuable addition to other interventions [18]. A systematic review on digital technologies in
TB treatment found that SMS reminders had no statistically significant effect on treatment
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adherence, while electronic medication monitors, i.e. medication boxes that record when the
box is opened, increased the probability of cure in one observational study and reduced missed
treatment doses in one trial [70].
Individualized support by nurses including PE support, SE support and possibly DOT
might also be a beneficial intervention in low-incidence countries. An important finding from
our Europe-wide survey among policy makers and nurse representatives also was that appoint-
ing a TB nurse to coordinate TB patient support (TB case management) may be considered a
best practice in European low-incidence countries [71]. A systematic review on SE support
and PE support of various forms found that most studies were conducted in in high-incidence
settings, and that both SE and PE support improved treatment results [16]. SE support com-
prised direct enablers (food supplements, dietary advice, travel reimbursement, vouchers for
local shops, clothing and hygiene kits), incentives (financial support, board games, newspapers
and household goods) as well as legal support and assistance in procuring documentation for
access to health care and social services. PE support included self-help groups, counselling,
home visits, community groups and psychotherapy combined. Studies conducted in America
before 2006 show that incentives and enablers, such as housing, monetary support, grocery
coupons and transport reimbursement, improve treatment adherence [72–75].
Ideally, TB case management should be tailored to the individual patient and aligned with
his or her expectations, i.e. patient-centred. Patient-centred care is much recommended in TB
care in both low- and high-incidence countries [76]. A patient-centred approach includes
exploring the patients’ needs for information, emotional needs, and life issues, finding com-
mon ground concerning the nature and the management of disease, enhancing prevention
and health promotion as well as the relationship between the patient and the provider [77].
Patients receiving support as described in the publications included in this systematic review
were frequently patients belonging to hard-to-reach groups such as immigrants, substance
abusers, homeless and prisoners. A risk-group-focussed approach has been recommended by
the WHO for countries progressing towards elimination [1]. The type and intensity of support
needed is, however, not only dependent on the presence or absence of certain risk factors but
also on individual patient characteristics [6]. Even within risk groups the need for support may
differ between individuals and it is not one size fits all. In general, to allow a patient-centred
approach, the patient’s needs are required to be assessed before implementation of treatment
and support [77]. It may be essential to train health care workers in how to assess these needs
and how to involve patients in the decision process.
Our review provided inconclusive evidence on the effectiveness of DOT in low-incidence
countries but suggests that VOT might prioritized over traditional forms of DOT to improve
patient and provider acceptance. A previous systematic review on DOT in both high and low-
incidence settings concluded that TB cure and treatment completion did not improve substan-
tially with DOT versus self-administered treatment [17]. Additionally, it showed that treat-
ment completion or cure did not differ between patients who received DOT at home by family
member or community health workers and patients who received DOT provided at the health
facility by health workers [17]. In our review there was also no clear benefit of DOT for risk
group patients. While peer DOT for substance abusers lead to positive effects on treatment
adherence [64] while there was no correlation between DOT and treatment adherence in a
population, in which DOT was given with priority to patients at risk of non-adherence [30]. A
previous systematic review by Heuvelings et al. (2017) on TB treatment adherence interven-
tions in hard-to reach populations in countries with low and medium TB incidence similarly
concluded that DOT may improve adherence in only certain risk populations including home-
less populations as well as migrants, prisoners and people living with HIV [20].
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Similar to previously published literature [17,78–80], our review found that provision of
traditional forms of DOT is surrounded with challenges for patients and providers, indicating
a need for innovations. Only two studies included in this review found that patients appreciate
DOT [56,58]; DOT combined with SE-, PE- and HE support for homeless patients reported
patient-empowerment [56]. Migrants experienced DOT as an expression of care, especially
when they were living very isolated [58]. Several other publications included in this review
reported obstacles related to DOT such as patients feeling humiliated because DOT restricted
their social life as they had to be at home during certain time slots for the DOT [58]. Also
financial barriers through travel time and costs were reported, either for the patient when
DOT is provided at the health facility or for the health care provider when DOT is provided at
the patient’s home [39,44,54,57,65]. A substantial body of literature has already described
obstacles and ethical concerns related to conventional DOT and questioned its’ effectiveness
[17,78–80], and the need for new more flexible forms of DOT approaches has been expressed
[80]. Few approaches addressing these obstacles related to more conventional DOT are identi-
fied by this review: only VOT and the use of peers. Use of peers increased adherence, which
may be explained by reduced social distance between patient and provider [64]. VOT is
described as an alternative to reduce travel time and costs for both patients and providers and
to increase privacy [39,44,65]. As VOT can be provided at any place, if there is internet con-
nection, it may also be easier to incorporate it into the patients’ everyday life [39,44,65]. The
VOT studies conducted showed that adherence is similar to health facility- and home-based
DOT [39,65]. The 2017 update of the WHO Guideline [76] for treatment of drug-susceptible
TB and patient care states that VOT may replace DOT if the video communication technology
is available and can be appropriately organized and operated by health care providers and
patients. Further research will be needed to determine how VOT can best be combined with
other treatment support resulting in satisfaction by both patients and health care workers, and
in a positive treatment result.
Integrating digital health interventions in TB patients support may be beneficial for patients
and providers, especially in low TB incidence countries. Both interventions identified in our
review, VOT and blogging about MDR-TB, were appreciated by patients as well as providers.
A recently published systematic review on the impact of digital health technologies on TB
treatment showed that provision of SMS reminders and electronic medication monitors until
now have been evaluated only in high-incidence countries [70] The implementation and eval-
uations of digital health in TB patient support interventions in low-incidence countries yet
appear to be scarce. but. Especially for low-incidence, high-resource countries it may be useful
to conduct further research on the value of digital health interventions in TB patient support.
Digital health is expected to be increasingly implemented in TB patient support as information
and communication technology is becoming more widely available and affordable, especially
in high-income countries [11,81]. Digital health could be supportive to the need for more flexi-
bility in patient support in general and in treatment supervision specifically. In addition to
VOT, there are substantially more opportunities to use digital health solutions in patient sup-
port interventions such as a one-stop internet hub that links up to different services of rele-
vance to TB care and health education [11]. These innovations may contribute to making
support not only more flexible and more patient-friendly but possibly also more efficient and
future-proof taking into account the decline of both patients and specialized TB health care
providers in low incidence countries.
There were some limitations to this study. The literature review yielded only a small num-
ber of studies, especially studies including comparative quantitative outcomes of patient sup-
port interventions were scarce. Even fewer studies measure clinical outcomes such as cure and
treatment failure which would be of greater importance to patient and providers compared to
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adherence measures only. Further, the studies were of low quality and studies and interven-
tions described in this review were highly variable due to the design of the review aiming to
provide an overview of patient support interventions implemented. Due to the small number
of studies measuring quantitative outcomes and a large variation in interventions applied, out-
comes measured and study populations among these studies could not be quantitatively syn-
thesized and analysed.
Although the finding of this study are insufficient to provide recommendations on effective
patients support in low incidence countries, our study identified some interventions that were
effective and/ or appreciated by patients which would be useful to subject to further research.
Furthermore, the framework we applied, with different patient support intervention categories
(DOT, HE support, SE support, PE support and other), provides the opportunity to assess for
the individual patients more systematically what categories of support are needed and to
decide on the level of support e.g. on a scale of 1 (low), 2 (medium) and 3 (high). A standard-
ised approach of defining the type and level of support to be provided will allow evaluating the
complex nature of patient support. Further research is needed to determine for low-incidence
countries how patients can best be involved in the decision-making process and to determine
which support is most effective and efficient for these countries. This should be done taking
into account the individual needs of the patients, risk group policy, the resources of the health
care system and digital innovations.
Conclusion
We provided an overview of support interventions currently implemented for TB patients in
low-incidence countries and the evidence on its effects on treatment-related outcomes. Our
review identified limited published evidence on effectiveness of patient support interventions
in low-incidence countries, although we did identify a number of successful patient support
interventions and possible best practices. Further research will be needed to verify these best
practices and to determine which patient support is most effective and efficient.
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